Particle.news
Download on the App Store

White House Tightens Control of HHS, Elevates Chris Klomp as Kennedy’s Deputy

The shift reflects concern that Robert F. Kennedy Jr.’s vaccine-focused agenda poses political risks before the 2026 midterms.

Overview

  • Citing the Wall Street Journal, the administration has centralized HHS operations and messaging to reduce political exposure ahead of the elections.
  • Medicare chief Chris Klomp has been elevated to serve as deputy with broad operational authority and a mandate to emphasize priorities like affordability and nutrition.
  • HHS Deputy Secretary Jim O’Neill has been removed from his Senate-confirmed role, and oversight of the FDA has been reassigned to ease internal friction.
  • Aides point to missteps under Kennedy, including a slow response to a Texas measles outbreak, backlash over mental-health grant cuts, and tensions tied to a generic abortion pill approval.
  • Kennedy retains President Trump’s personal support, even as reporting cites a recent Annenberg survey indicating declining public confidence in health agencies since Kennedy took charge.